The CA 125 Test measures the level of cancer antigen 125 in the blood, a biomarker associated with ovarian cancer. Elevated CA 125 levels can indicate the presence of ovarian cancer, but they are not exclusive to this condition, as certain benign conditions can also cause an increase. This test is primarily used to monitor the effectiveness of ovarian cancer treatment, detect cancer recurrence, and assess risk in individuals with a family history or genetic predisposition to ovarian cancer.

The CA 125 Test is essential for women at risk of ovarian cancer, especially those with a family history of the disease or inherited BRCA 1 & BRCA 2 genes. Elevated CA 125 levels may indicate cancer presence or progression, which makes this test crucial for monitoring treatment efficacy in diagnosed patients and detecting potential recurrence in recovered patients. Early identification through CA 125 testing enables timely intervention, helping improve patient outcomes in ovarian cancer care.

Test price for other cities